Abhay Joshi

EVP & Chief Technical Officer, COTHERIX INC.

Companies

Revance Therapeutics, Inc.President Feb 19, 2020 to Mar 17, 2022¹
Revance Therapeutics, Inc.Chief operating officer Dec 16, 2015 to Mar 17, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Revance Therapeutics, Inc.120,708 shares³Mar 15, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 15, 2022Shares withheld for tax 2,607 shares at $15.79 of Revance Therapeutics, Inc.³
Feb 15, 2022Shares withheld for tax 2,902 shares at $13.35 of Revance Therapeutics, Inc.⁴
Feb 15, 2022Shares withheld for tax 2,151 shares at $13.35 of Revance Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRevance Therapeutics, Inc., President
2
SEC EDGARRevance Therapeutics, Inc., Chief operating officer
3
SEC EDGARRevance Therapeutics, Inc. shares after the filing of Mar 15, 2022
4
SEC EDGARForm 4 filed Feb 17, 2022